Activation of the YAP–FGF2–MAPK pathway endows glioma cells with the ability to enhance DNA repair, promote cell cycle progression, and inhibit apoptosis, leading to cell survival after radiation. The gene discussed is FGF2; the disease is central nervous system cancer.